{"id":"f7652816-1e14-4070-8604-0a45b6f78a9a","arxiv_id":"2602.03730","paper_version":2,"verdict":"UNVERDICTED","confidence":"LOW","novelty_score":7.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":0,"one_line_summary":"SCOPE and REACH are unbiased estimators that deliver Monte Carlo-level accuracy for EHR outcome prediction using 2.5-80x fewer tokens via direct use of conditional probabilities and variance reduction guarantees.","lead":"The paper introduces SCOPE and REACH estimators to improve efficiency of clinical outcome prediction from generative EHR foundation models by leveraging next-token probabilities instead of full Monte Carlo trajectory sampling. These methods claim to match sampling accuracy with substantially lower computational cost while preserving calibration, especially for rare outcomes.","discovery_kind":"unclear","skeptic_critique":{"model":"grok-4.3","headline":"No significant objection identified","rationale":"The reader's weakest assumption targets practical model fidelity rather than the theoretical properties claimed. Because the strongest claim is a set of general statistical identities that hold by construction for any autoregressive model once the conditioning is well-defined, the argument has no load-bearing soft spot at the level of internal logic. Full-text verification of the derivations would still be useful but does not alter the verdict on the stated claims.","tokens_in":1762,"tokens_out":289,"duration_ms":26369,"concrete_test":"Extract the exact definitions of SCOPE and REACH from the methods section and re-derive the unbiasedness and variance-reduction statements using only the law of total expectation and law of total variance; confirm both hold without additional assumptions on the outcome function or token dependencies.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claims (unbiasedness of SCOPE and REACH, variance reduction of REACH over Monte Carlo for any model/outcome, and REACH as Rao-Blackwellization of naive importance sampling preserving the non-outcome token distribution) follow directly from standard results in Monte Carlo integration and the Rao-Blackwell theorem once the estimators are defined as conditional expectations over the model's next-token distributions. The abstract states the proofs exist; no internal inconsistency, hidden approximation, or non-general assumption is visible in the claim structure that would invalidate the mathematical argument.","agreement_with_reader":"agree"},"referee_report":{"model":"grok-4.3","summary":"The manuscript introduces SCOPE (Sum of Conditional Outcome Probability Estimator) and REACH (Risk Estimation from Anticipated Conditional Hazards) as alternatives to Monte Carlo sampling for clinical outcome prediction with generative EHR foundation models. It claims proofs that both estimators are unbiased, that REACH guarantees variance reduction over Monte Carlo for any model and outcome via Rao-Blackwellization of importance sampling that preserves the non-outcome token distribution, and that SCOPE enables reuse of a single sample pool across outcomes. Empirical results on 11 outcomes from MIMIC-IV and UChicago datasets report that the estimators match 100-sample Monte Carlo accuracy with median token reductions of 2.5×–3.4× (exceeding 80× for rarest outcomes) while preserving calibration.","tokens_in":1854,"tokens_out":497,"duration_ms":24153,"significance":"If the unbiasedness and variance-reduction claims hold, the work provides a practical, theoretically grounded reduction in inference cost for generative EHR models, particularly valuable for rare high-impact outcomes where Monte Carlo variance is prohibitive. The complementary strengths of SCOPE (cross-outcome reuse at zero marginal cost) and REACH (per-task variance guarantee) are a clear strength, and the application of standard Monte Carlo and Rao-Blackwell tools to this domain is cleanly executed.","major_comments":[],"minor_comments":[{"comment":"Abstract and §4: the statement that SCOPE and REACH 'match 100-sample Monte Carlo accuracy' should specify the exact metric (e.g., AUC, Brier score, or calibration slope) and the tolerance used to declare equivalence; without this the reported token reductions are difficult to interpret.","section":"Abstract, §4"},{"comment":"§3.2: the proof that REACH is a Rao-Blackwellization of naive importance sampling would benefit from an explicit statement of the conditioning sigma-algebra and the preservation of the non-outcome token marginal; a short lemma isolating this step would improve readability.","section":"§3.2"},{"comment":"Table 2: the per-outcome token-reduction factors are reported only as medians across models; adding inter-quartile ranges or per-model breakdowns would strengthen the claim that gains are consistent rather than driven by a few favorable cases.","section":"Table 2"}],"recommendation":"minor_revision","confidential_remarks":null},"author_rebuttal":{"model":"grok-4.3","summary":"We thank the referee for the accurate summary of our work and for highlighting the practical value of the unbiasedness and variance-reduction properties of SCOPE and REACH. We are pleased with the recommendation for minor revision. No specific major comments were raised in the report, so we have no changes to propose at this time but are happy to incorporate any additional feedback the editor or referee may provide.","responses":[],"tokens_in":1337,"tokens_out":95,"duration_ms":19017,"standing_objections":[]},"desk_editor":{"model":"grok-4.3","letter":"The main thing to know is that SCOPE and REACH let generative EHR models match 100-sample Monte Carlo accuracy for outcome prediction with far fewer tokens generated, especially on rare events, and the paper backs this with unbiasedness proofs plus a variance reduction guarantee for REACH.","headline":"SCOPE and REACH cut token use by 2.5-80x for EHR generative predictions while staying unbiased and calibrated.","tokens_in":2373,"tokens_out":125,"would_cite":true,"duration_ms":18660,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":{"model":"grok-4.3","evidence":[],"headline":"Standard Monte Carlo + Rao-Blackwell estimators for EHR trajectories; no RS cost, distinction, or φ-ladder structure","alignment":"orthogonal","rationale":"The paper's core machinery (SCOPE as sum of conditional next-token probabilities, REACH as conditional survival on outcome-free backbones, unbiasedness via tower rule, variance reduction via law of total variance) is classical Monte Carlo integration and Rao-Blackwellization. It never invokes J-cost, reciprocal symmetry, golden-ratio fixed points, 8-tick periodicity, or any forcing from a single distinction. The RS theorems (reality_from_one_distinction, J-uniqueness via Aczél, Alexander-duality D=3, etc.) are therefore neither matched nor contradicted.","tokens_in":56493,"confidence":"high","tokens_out":169,"duration_ms":12820,"cache_read_input_tokens":128,"cache_creation_input_tokens":0},"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.3","headline":"SCOPE and REACH estimators enable unbiased clinical outcome prediction from generative EHR models with far fewer tokens than Monte Carlo sampling.","keywords":["generative EHR models","outcome prediction","Monte Carlo sampling","variance reduction","unbiased estimators","Rao-Blackwellization","SCOPE","REACH"],"falsifier":"A comparison where SCOPE or REACH estimates on a fixed model deviate from outcome frequencies obtained by running millions of Monte Carlo trajectories on the same model.","tokens_in":2673,"feed_emoji":"📊","tokens_out":762,"duration_ms":42945,"temperature":0.7,"pith_summary":"Generative foundation models for electronic health records predict clinical outcomes by simulating future trajectories via Monte Carlo sampling, but this suffers from sparse estimates, high computational cost, and high variance. The paper introduces the Sum of Conditional Outcome Probability Estimator (SCOPE) and Risk Estimation from Anticipated Conditional Hazards (REACH) that leverage next-token probability distributions. Both estimators are proven unbiased, with REACH guaranteeing variance reduction over Monte Carlo for any model and outcome as a Rao-Blackwellization of importance sampling. Across 11 outcomes in MIMIC-IV and UChicago data, they match 100-sample Monte Carlo accuracy with median token reductions of 2.5 to 3.4 times and over 80 times for rare outcomes, while preserving calibration. This reduces the inference budget for generative EHR models, making them more practical for clinical use especially on rare high-impact events.","feed_headline":"Estimators cut EHR prediction tokens by 2.5x to 80x","feed_subtitle":"SCOPE and REACH match 100-sample Monte Carlo accuracy with preserved calibration for 11 clinical outcomes.","key_machinery":"The SCOPE (Sum of Conditional Outcome Probability Estimator) and REACH (Risk Estimation from Anticipated Conditional Hazards) estimators that compute outcome probabilities by summing or anticipating conditional probabilities drawn from next-token distributions.","core_discovery":"The central claim is that SCOPE and REACH are unbiased estimators that use the generative model's next-token probabilities to compute outcome risks more efficiently than full trajectory Monte Carlo sampling, with REACH providing guaranteed variance reduction via Rao-Blackwellization of any naive importance sampling scheme that preserves the non-outcome token distribution.","pith_inferences":["The same estimators could reduce sampling costs in any generative model that produces sequential token probabilities, such as time-series or language models.","For clinical systems tracking many outcomes simultaneously, SCOPE would minimize total generation cost while REACH supplies per-outcome variance control.","If next-token modeling accuracy improves, these estimators would automatically deliver larger efficiency gains without changes to the sampling procedure.","A direct test would be to measure wall-clock inference time on a fixed hardware budget when replacing Monte Carlo with REACH for rare-event screening."],"forward_implications":["Both estimators remain unbiased for any generative model and any outcome.","REACH guarantees variance reduction over Monte Carlo sampling for every model and outcome.","REACH is a Rao-Blackwellization of naive importance sampling schemes that preserve the non-outcome token distribution.","SCOPE reuses one sampled pool across arbitrary numbers of outcomes at no marginal generation cost.","Empirical accuracy matching 100-sample Monte Carlo is achieved with 2.5x to 3.4x median token reductions and over 80x for the rarest outcomes, with calibration preserved."],"fun_headline_variants":["SCOPE and REACH cut EHR prediction tokens 2.5x-80x","Estimators match Monte Carlo accuracy using fewer tokens","REACH guarantees lower variance for EHR predictions","SCOPE reuses samples for multiple EHR outcomes at no cost"],"cache_read_input_tokens":64,"weakest_assumption_plain":"The generative model's next-token probability distributions accurately reflect the underlying data distribution and can be directly leveraged for conditional outcome probability calculations without further approximation or model-specific adjustments.","fun_headline_variants_meta":{"raw":{"variants":["SCOPE and REACH cut EHR prediction tokens 2.5x-80x","Estimators match Monte Carlo accuracy using fewer tokens","REACH guarantees lower variance for EHR predictions","SCOPE reuses samples for multiple EHR outcomes at no cost"]},"model":"grok-4.3","cost_usd":0.007279,"raw_usage":{"total_tokens":3364,"prompt_tokens":690,"num_sources_used":0,"completion_tokens":64,"cost_in_usd_ticks":72787000,"prompt_tokens_details":{"text_tokens":690,"audio_tokens":0,"image_tokens":0,"cached_tokens":256},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":2610,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":690,"tokens_out":64,"duration_ms":20217,"temperature":1.0,"reasoning_tokens":2610,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-05-16T07:18:35.675829+00:00","model_set":{"reader":"grok-4.3"},"falsifier":"A comparison where SCOPE or REACH estimates on a fixed model deviate from outcome frequencies obtained by running millions of Monte Carlo trajectories on the same model.","supporting_citations":[],"review_version":1}